Asia Pacific Hyaluronic Acid Market Size & Outlook
Asia Pacific hyaluronic acid market, 2017-2030 (US$M)
Related Markets
Asia Pacific hyaluronic acid market highlights
- The Asia Pacific hyaluronic acid market generated a revenue of USD 3,035.2 million in 2022.
- The market is expected to grow at a CAGR of 8.3% from 2023 to 2030.
- In terms of segment, osteoarthritis was the largest revenue generating application in 2022.
- Ophthalmic is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 3,035.2 million |
| Market revenue in 2030 | USD 5,723.7 million |
| Growth rate | 8.3% (CAGR from 2022 to 2030) |
| Largest segment | Osteoarthritis |
| Fastest growing segment | Ophthalmic |
| Historical data covered | 2017 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
| Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 32.2% of the global hyaluronic acid market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,723.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hyaluronic Acid Market Scope
Hyaluronic Acid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific hyaluronic acid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Osteoarthritis was the largest segment with a revenue share of 42.91% in 2022. Horizon Databook has segmented the Asia Pacific hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
Countries such as India and China have large geriatric population providing a wide potential customer base for hyaluronic acid. Moreover, increasing demand for esthetic treatment in Japan, South Korea, and certain Southeast Asian countries are among factors expected to propel market growth in Asia Pacific.
Furthermore, Asian countries have a high prevalence of diabetes, which is one of the risk factors for osteoarthritis and cataract. For instance, according to International Diabetes Federation, 88 million adults were living with diabetes in Southeast Asia in 2019.
By 2045, this figure is projected to reach 153 million. The region has a high presence of undiagnosed patient population having osteoarthritis, diabetes, and ophthalmic disorders, especially cataract.
Reasons to subscribe to Asia Pacific hyaluronic acid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific hyaluronic acid market databook
-
Our clientele includes a mix of hyaluronic acid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific hyaluronic acid market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific hyaluronic acid market size, by country, 2017-2030 (US$M)
Asia Pacific Hyaluronic Acid Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
